Qi‐Lun Lai

510 total citations
37 papers, 295 citations indexed

About

Qi‐Lun Lai is a scholar working on Neurology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Qi‐Lun Lai has authored 37 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Neurology, 6 papers in Pathology and Forensic Medicine and 6 papers in Epidemiology. Recurrent topics in Qi‐Lun Lai's work include Autoimmune Neurological Disorders and Treatments (19 papers), Peripheral Neuropathies and Disorders (16 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Qi‐Lun Lai is often cited by papers focused on Autoimmune Neurological Disorders and Treatments (19 papers), Peripheral Neuropathies and Disorders (16 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Qi‐Lun Lai collaborates with scholars based in China and United States. Qi‐Lun Lai's co-authors include Yinxi Zhang, Chun‐Hong Shen, Meng‐Ting Cai, Yang Zheng, Meiping Ding, Song Qiao, Gao‐Li Fang, Tianyi Zhang, Yi Guo and Junjun Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Epilepsia.

In The Last Decade

Qi‐Lun Lai

33 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qi‐Lun Lai China 11 162 62 52 47 41 37 295
Shakti Agrawal United Kingdom 11 143 0.9× 73 1.2× 91 1.8× 35 0.7× 67 1.6× 16 305
Muralidharan Sargurupremraj United States 8 86 0.5× 61 1.0× 40 0.8× 36 0.8× 36 0.9× 14 283
Muhammad Talal Alrifai Saudi Arabia 12 136 0.8× 157 2.5× 48 0.9× 65 1.4× 82 2.0× 28 444
R. Schwendimann United States 10 69 0.4× 73 1.2× 20 0.4× 29 0.6× 24 0.6× 27 323
Fafa Tian China 11 90 0.6× 85 1.4× 34 0.7× 84 1.8× 30 0.7× 27 332
Marios Kaliakatsos United Kingdom 12 75 0.5× 83 1.3× 114 2.2× 17 0.4× 38 0.9× 31 411
Deborah L. Renaud United States 11 180 1.1× 233 3.8× 29 0.6× 33 0.7× 79 1.9× 41 470
Eleonora Mauri Italy 7 80 0.5× 76 1.2× 84 1.6× 21 0.4× 11 0.3× 22 332
Karthik Muthusamy India 10 50 0.3× 118 1.9× 17 0.3× 27 0.6× 42 1.0× 43 268

Countries citing papers authored by Qi‐Lun Lai

Since Specialization
Citations

This map shows the geographic impact of Qi‐Lun Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi‐Lun Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi‐Lun Lai more than expected).

Fields of papers citing papers by Qi‐Lun Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi‐Lun Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi‐Lun Lai. The network helps show where Qi‐Lun Lai may publish in the future.

Co-authorship network of co-authors of Qi‐Lun Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Qi‐Lun Lai. A scholar is included among the top collaborators of Qi‐Lun Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi‐Lun Lai. Qi‐Lun Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lai, Qi‐Lun, Meng‐Ting Cai, Guihua Fang, et al.. (2025). Neurofilament light chain levels in neuronal surface antibody-associated autoimmune encephalitis: a systematic review and meta-analysis. Translational Psychiatry. 15(1). 25–25.
2.
Liu, Lu, et al.. (2024). Effects of Hypertension on Alzheimer's Disease: Updates in Pathophysiological and Neuroimaging Findings. Journal of Integrative Neuroscience. 23(8). 143–143.
3.
Zhang, Tianyi, et al.. (2024). Clinical and Paraclinical Characterizations, Management, and Prognosis in DPPX Antibody-Associated Encephalitis. Neurology Neuroimmunology & Neuroinflammation. 12(2). e200350–e200350. 1 indexed citations
4.
Lai, Qi‐Lun, Meng‐Ting Cai, Gao‐Li Fang, et al.. (2024). Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS): contemporary advances and current controversies. Journal of Neurology. 271(4). 1747–1766. 2 indexed citations
5.
Lai, Qi‐Lun, et al.. (2023). Criteria for myelin oligodendrocyte glycoprotein antibody‐associated disease: Balancing underdiagnosis with overdiagnosis. SHILAP Revista de lepidopterología. 3(4). 1 indexed citations
6.
Cai, Meng‐Ting, et al.. (2023). Myelin oligodendrocyte glycoprotein antibody-associated disease preceding primary central nervous system lymphoma: causality or coincidence?. Neurological Sciences. 44(10). 3711–3715. 2 indexed citations
7.
Lai, Qi‐Lun, Meng‐Ting Cai, Gao‐Li Fang, et al.. (2023). Myelin oligodendrocyte glycoprotein antibody and N-methyl-d-aspartate receptor antibody overlapping syndrome: insights from the recent case reports. Clinical & Experimental Immunology. 215(1). 27–36. 5 indexed citations
8.
Lai, Qi‐Lun, Meng‐Ting Cai, Gao‐Li Fang, et al.. (2023). Anti-adenylate kinase 5 encephalitis: Clinical characteristics, diagnosis, and management of this rare entity. Journal of Translational Autoimmunity. 7. 100218–100218. 3 indexed citations
9.
Cai, Meng‐Ting, Qi‐Lun Lai, Yang Zheng, et al.. (2022). First-line immunotherapy of neuronal surface antibody-mediated autoimmune encephalitis: Assessment of therapeutic effectiveness and cost-efficiency. Multiple Sclerosis and Related Disorders. 66. 104071–104071. 4 indexed citations
11.
Cai, Meng‐Ting, Yang Zheng, Qi‐Lun Lai, et al.. (2022). Phenotyping the late- and younger-onset neuronal surface antibody-mediated autoimmune encephalitis: a multicenter study. Clinical & Experimental Immunology. 211(1). 78–83. 3 indexed citations
13.
Lai, Qi‐Lun, Meng‐Ting Cai, Yang Zheng, et al.. (2022). Evaluation of CSF albumin quotient in neuronal surface antibody-associated autoimmune encephalitis. Fluids and Barriers of the CNS. 19(1). 93–93. 10 indexed citations
14.
Lai, Qi‐Lun, Meng‐Ting Cai, Junjun Wang, et al.. (2022). Detecting vulnerable carotid plaque and its component characteristics: Progress in related imaging techniques. Frontiers in Neurology. 13. 982147–982147. 14 indexed citations
15.
Guo, Yi, Meng‐Ting Cai, Qi‐Lun Lai, et al.. (2021). Anti-Ma2 Antibody-Associated Paraneoplastic Neurological Syndromes: A Pilot Study. Brain Sciences. 11(12). 1577–1577. 4 indexed citations
16.
Cai, Meng‐Ting, Yang Zheng, Sa Wang, et al.. (2021). Clinical Relevance of Cerebrospinal Fluid Antibody Titers in Anti-N-Methyl-d-Aspartate Receptor Encephalitis. Brain Sciences. 12(1). 4–4. 10 indexed citations
17.
Cai, Meng‐Ting, Qi‐Lun Lai, Yang Zheng, et al.. (2021). Validation of the Clinical Assessment Scale for Autoimmune Encephalitis: A Multicenter Study. Neurology and Therapy. 10(2). 985–1000. 20 indexed citations
18.
Lai, Qi‐Lun, Yinxi Zhang, Meng‐Ting Cai, et al.. (2021). Efficacy and safety of immunosuppressive therapy in myelin oligodendrocyte glycoprotein antibody–associated disease: a systematic review and meta-analysis. Therapeutic Advances in Neurological Disorders. 14. 4203335245–4203335245. 9 indexed citations
19.
Lai, Qi‐Lun, Meng‐Ting Cai, Yang Zheng, et al.. (2021). Seasonal variation in autoimmune encephalitis: A multi-center retrospective study. Journal of Neuroimmunology. 359. 577673–577673. 12 indexed citations
20.
Zhang, Tianyi, Meng‐Ting Cai, Yang Zheng, et al.. (2021). Anti-Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor Encephalitis: A Review. Frontiers in Immunology. 12. 652820–652820. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026